Organon & Co. (OGN) Financials

OGN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 13.0 billion 12.1 billion
Dec. 31, 2025 12.9 billion 12.1 billion
Sept. 30, 2025 13.6 billion 12.6 billion
June 30, 2025 13.5 billion 12.8 billion

OGN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 188.0 million 19.0 million
Dec. 31, 2025 96.0 million 7.0 million
Sept. 30, 2025 149.0 million 24.0 million
June 30, 2025 181.0 million 22.0 million

OGN Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 146.0 million
Dec. 31, 2025 -205.0 million
Sept. 30, 2025 160.0 million
June 30, 2025 145.0 million

OGN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 1.1 billion 8.6 billion -
Dec. 31, 2025 574.0 million 8.6 billion 116.0 million
Sept. 30, 2025 672.0 million 8.8 billion -
June 30, 2025 599.0 million 8.8 billion -

OGN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 262.9 million
Dec. 31, 2025 260.2 million
Sept. 30, 2025 260.7 million
June 30, 2025 260.2 million

OGN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 37.0 million 93.0 million 424.0 million -
Dec. 31, 2025 45.0 million 91.0 million 433.0 million -
Sept. 30, 2025 115.0 million 84.0 million 415.0 million -
June 30, 2025 39.0 million 95.0 million 453.0 million -

OGN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.5 billion 677.0 million
Dec. 31, 2025 1.5 billion 748.0 million
Sept. 30, 2025 1.6 billion 745.0 million
June 30, 2025 1.6 billion 720.0 million

OGN

Price: $13.40

52 week price:
5.69
13.48

Dividend Yield: 0.60%

5-year range yield:
0.60%
7.65%

Forward Dividend Yield: 0.60%

Payout Ratio: 28.87%

Payout Ratio Range:
-2.54%
127.59%

Dividend Per Share: 0.08 USD

Earnings Per Share: 0.93 USD

P/E Ratio: 14.31

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United States

Volume: 1.6 million

Market Capitalization: 3.5 billion

Average Dividend Frequency: 4

Years Paying Dividends: 6

DGR3: -7.74%

Links: